Accounting for expected attrition in the planning of cluster randomized trials for assessing treatment effect heterogeneity
- PMID: 37024809
- PMCID: PMC10077680
- DOI: 10.1186/s12874-023-01887-8
Accounting for expected attrition in the planning of cluster randomized trials for assessing treatment effect heterogeneity
Erratum in
-
Correction: Accounting for expected attrition in the planning of cluster randomized trials for assessing treatment effect heterogeneity.BMC Med Res Methodol. 2023 Jun 7;23(1):135. doi: 10.1186/s12874-023-01932-6. BMC Med Res Methodol. 2023. PMID: 37286955 Free PMC article. No abstract available.
Abstract
Background: Detecting treatment effect heterogeneity is an important objective in cluster randomized trials and implementation research. While sample size procedures for testing the average treatment effect accounting for participant attrition assuming missing completely at random or missing at random have been previously developed, the impact of attrition on the power for detecting heterogeneous treatment effects in cluster randomized trials remains unknown.
Methods: We provide a sample size formula for testing for a heterogeneous treatment effect assuming the outcome is missing completely at random. We also propose an efficient Monte Carlo sample size procedure for assessing heterogeneous treatment effect assuming covariate-dependent outcome missingness (missing at random). We compare our sample size methods with the direct inflation method that divides the estimated sample size by the mean follow-up rate. We also evaluate our methods through simulation studies and illustrate them with a real-world example.
Results: Simulation results show that our proposed sample size methods under both missing completely at random and missing at random provide sufficient power for assessing heterogeneous treatment effect. The proposed sample size methods lead to more accurate sample size estimates than the direct inflation method when the missingness rate is high (e.g., ≥ 30%). Moreover, sample size estimation under both missing completely at random and missing at random is sensitive to the missingness rate, but not sensitive to the intracluster correlation coefficient among the missingness indicators.
Conclusion: Our new sample size methods can assist in planning cluster randomized trials that plan to assess a heterogeneous treatment effect and participant attrition is expected to occur.
Keywords: Cluster randomized trial; Heterogeneity of treatment effect; Intracluster correlation coefficient; Missing at random; Missing completely at random; Missing data; Power calculation.
© 2023. The Author(s).
Conflict of interest statement
None.
Figures


Similar articles
-
Sample size requirements for testing treatment effect heterogeneity in cluster randomized trials with binary outcomes.Stat Med. 2023 Nov 30;42(27):5054-5083. doi: 10.1002/sim.9901. Epub 2023 Sep 14. Stat Med. 2023. PMID: 37974475 Free PMC article.
-
Imputation strategies for missing binary outcomes in cluster randomized trials.BMC Med Res Methodol. 2011 Feb 16;11:18. doi: 10.1186/1471-2288-11-18. BMC Med Res Methodol. 2011. PMID: 21324148 Free PMC article.
-
Properties and pitfalls of weighting as an alternative to multilevel multiple imputation in cluster randomized trials with missing binary outcomes under covariate-dependent missingness.Stat Methods Med Res. 2020 May;29(5):1338-1353. doi: 10.1177/0962280219859915. Epub 2019 Jul 11. Stat Methods Med Res. 2020. PMID: 31293199
-
Imputation strategies for missing continuous outcomes in cluster randomized trials.Biom J. 2008 Jun;50(3):329-45. doi: 10.1002/bimj.200710423. Biom J. 2008. PMID: 18537126 Review.
-
Imputation of missing covariate in randomized controlled trials with a continuous outcome: Scoping review and new results.Pharm Stat. 2020 Nov;19(6):840-860. doi: 10.1002/pst.2041. Epub 2020 Jun 8. Pharm Stat. 2020. PMID: 32510791 Free PMC article.
Cited by
-
Interventions for Compassion Fatigue in Healthcare Providers-A Systematic Review of Randomised Controlled Trials.Healthcare (Basel). 2024 Jan 11;12(2):171. doi: 10.3390/healthcare12020171. Healthcare (Basel). 2024. PMID: 38255060 Free PMC article. Review.
-
Assessing treatment effect heterogeneity in the presence of missing effect modifier data in cluster-randomized trials.Stat Methods Med Res. 2024 May;33(5):909-927. doi: 10.1177/09622802241242323. Epub 2024 Apr 3. Stat Methods Med Res. 2024. PMID: 38567439 Free PMC article.
-
Estimates of intra-cluster correlation coefficients from 2018 USA Medicare data to inform the design of cluster randomized trials in Alzheimer's and related dementias.Trials. 2024 Oct 30;25(1):732. doi: 10.1186/s13063-024-08404-2. Trials. 2024. PMID: 39478608 Free PMC article.
-
Sample size requirements for testing treatment effect heterogeneity in cluster randomized trials with binary outcomes.Stat Med. 2023 Nov 30;42(27):5054-5083. doi: 10.1002/sim.9901. Epub 2023 Sep 14. Stat Med. 2023. PMID: 37974475 Free PMC article.
-
Correction: Accounting for expected attrition in the planning of cluster randomized trials for assessing treatment effect heterogeneity.BMC Med Res Methodol. 2023 Jun 7;23(1):135. doi: 10.1186/s12874-023-01932-6. BMC Med Res Methodol. 2023. PMID: 37286955 Free PMC article. No abstract available.
References
-
- Murray DM. Design and analysis of group-randomized trials: Monographs in Epidemiology and 1998.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources